Literature DB >> 24975140

Implications of peritoneal lavage cytology in resectable left-sided pancreatic cancer.

Yoshifumi Iwagami1, Hidetoshi Eguchi, Hiroshi Wada, Yoshito Tomimaru, Naoki Hama, Koichi Kawamoto, Shogo Kobayashi, Masaki Mori, Yuichiro Doki, Hiroaki Nagano.   

Abstract

PURPOSE: The aim of this study was to determine the utility of the peritoneal lavage cytology findings in predicting the clinical outcomes of resectable left-sided pancreatic cancer.
METHODS: Peritoneal lavage samples were collected from 39 consecutive patients who underwent surgery for left-sided pancreatic cancer between January 2000 and December 2010. We analyzed the correlations between the peritoneal lavage cytology findings and the clinical outcomes.
RESULTS: Five patients (12.8 %) had malignant cells in the cytology samples (positive cytology). This occurred more frequently in patients with vascular invasion (P = 0.008). Positive cytology was significantly associated with lower overall (P = 0.0007) and recurrent-free (P < 0.0001) survival rates. Positive cytology was an independent prognostic factor for recurrence (P = 0.022); it was closely associated with local recurrence, peritoneal recurrence and distant metastasis.
CONCLUSION: Surgeons should carefully consider the intraoperative diagnosis of peritoneal lavage cytology in patients with resectable left-sided pancreatic cancers, because patients with positive cytology are likely to experience recurrence.

Entities:  

Mesh:

Year:  2014        PMID: 24975140     DOI: 10.1007/s00595-014-0964-7

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  32 in total

1.  Positive peritoneal lavage cytology is a predictor of worse survival in locally advanced pancreatic cancer.

Authors:  Clancy J Clark; L William Traverso
Journal:  Am J Surg       Date:  2010-05       Impact factor: 2.565

2.  The influence of positive peritoneal cytology on survival in patients with pancreatic adenocarcinoma.

Authors:  Cristina R Ferrone; Barbara Haas; Laura Tang; Daniel G Coit; Yuman Fong; Murray F Brennan; Peter J Allen
Journal:  J Gastrointest Surg       Date:  2006-12       Impact factor: 3.452

3.  Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial.

Authors:  Helmut Oettle; Stefan Post; Peter Neuhaus; Klaus Gellert; Jan Langrehr; Karsten Ridwelski; Harald Schramm; Joerg Fahlke; Carl Zuelke; Christof Burkart; Klaus Gutberlet; Erika Kettner; Harald Schmalenberg; Karin Weigang-Koehler; Wolf-Otto Bechstein; Marco Niedergethmann; Ingo Schmidt-Wolf; Lars Roll; Bernd Doerken; Hanno Riess
Journal:  JAMA       Date:  2007-01-17       Impact factor: 56.272

4.  Pancreaticoduodenectomy and palliation in pancreatic carcinoma.

Authors:  K D Lillemoe; J L Cameron; C J Yeo; T A Sohn; A Nakeeb; P K Sauter; R H Hruban; R A Abrams; H A Pitt
Journal:  Gastroenterology       Date:  1997-03       Impact factor: 22.682

5.  Positive peritoneal cytology predicts unresectability of pancreatic adenocarcinoma.

Authors:  N B Merchant; K C Conlon; P Saigo; E Dougherty; M F Brennan
Journal:  J Am Coll Surg       Date:  1999-04       Impact factor: 6.113

6.  The implications of positive peritoneal lavage cytology in potentially resectable pancreatic cancer.

Authors:  Ryuji Yoshioka; Akio Saiura; Rintaro Koga; Junichi Arita; Nobuyuki Takemura; Yoshihiro Ono; Junji Yamamoto; Toshiharu Yamaguchi
Journal:  World J Surg       Date:  2012-09       Impact factor: 3.352

7.  Distal pancreatectomy: indications and outcomes in 235 patients.

Authors:  K D Lillemoe; S Kaushal; J L Cameron; T A Sohn; H A Pitt; C J Yeo
Journal:  Ann Surg       Date:  1999-05       Impact factor: 12.969

8.  Classification of pancreatic cancer: comparison of Japanese and UICC classifications.

Authors:  Shuji Isaji; Yoshifumi Kawarada; Shinji Uemoto
Journal:  Pancreas       Date:  2004-04       Impact factor: 3.327

9.  Clinical implications of peritoneal cytology in potentially resectable pancreatic cancer: positive peritoneal cytology may not confer an adverse prognosis.

Authors:  Suguru Yamada; Shin Takeda; Tsutomu Fujii; Shuji Nomoto; Naohito Kanazumi; Hiroyuki Sugimoto; Hideki Kasuya; Yasuhiro Kodera; Tetsuro Nagasaka; Satoshi Morita; Akimasa Nakao
Journal:  Ann Surg       Date:  2007-08       Impact factor: 12.969

10.  Implications of peritoneal cytology for staging of early pancreatic cancer.

Authors:  A L Warshaw
Journal:  Am J Surg       Date:  1991-01       Impact factor: 2.565

View more
  8 in total

1.  The basal nutritional state of PDAC patients is the dominant factor for completing adjuvant chemotherapy.

Authors:  Daisaku Yamada; Hidetoshi Eguchi; Tadafumi Asaoka; Hideo Tomihara; Takehiro Noda; Hiroshi Wada; Koichi Kawamoto; Kunihito Gotoh; Yutaka Takeda; Masahiro Tanemura; Masaki Mori; Yuichiro Doki
Journal:  Surg Today       Date:  2017-04-18       Impact factor: 2.549

Review 2.  No-touch isolation techniques for pancreatic cancer.

Authors:  Tamotsu Kuroki; Susumu Eguchi
Journal:  Surg Today       Date:  2016-03-01       Impact factor: 2.549

3.  Preoperative chemoradiotherapy does not compromise the feasibility of adjuvant chemotherapy for patients with pancreatic ductal adenocarcinoma.

Authors:  Hideo Tomihara; Hidetoshi Eguchi; Daisaku Yamada; Kunihito Gotoh; Koichi Kawamoto; Hiroshi Wada; Tadafumi Asaoka; Takehiro Noda; Yutaka Takeda; Masahiro Tanemura; Masaki Mori; Yuichiro Doki
Journal:  Surg Today       Date:  2016-09-01       Impact factor: 2.549

4.  The Significance of SCC and CEA mRNA in the Pleural Cavity After Lymphadenectomy in Esophageal Cancer Patients who Underwent Preoperative Treatment.

Authors:  Keijiro Sugimura; Hiroshi Miyata; Masaaki Motoori; Takeshi Omori; Yoshiyuki Fujiwara; Masahiko Yano
Journal:  World J Surg       Date:  2018-03       Impact factor: 3.352

5.  The investigation of the survival time after recurrence in patients with pancreatic ductal adenocarcinoma for individualization of adjuvant chemotherapy.

Authors:  Daisaku Yamada; Hidetoshi Eguchi; Yoshifumi Iwagami; Tadafumi Asaoka; Takehiro Noda; Koichi Kawamoto; Kunihito Gotoh; Shogo Kobayashi; Masaki Mori; Yuichiro Doki
Journal:  Surg Today       Date:  2018-05-17       Impact factor: 2.549

Review 6.  Prognostic significance of positive peritoneal cytology in resectable pancreatic cancer: a systemic review and meta-analysis.

Authors:  Feng Cao; Jia Li; Ang Li; Fei Li
Journal:  Oncotarget       Date:  2017-02-28

7.  Impact of tumor size on survival of patients with resected pancreatic ductal adenocarcinoma: a systematic review and meta-analysis.

Authors:  Debang Li; Bin Hu; Yanming Zhou; Tao Wan; Xiaoying Si
Journal:  BMC Cancer       Date:  2018-10-16       Impact factor: 4.430

8.  Positive Intraoperative Peritoneal Lavage Cytology is a Negative Prognostic Factor in Pancreatic Ductal Adenocarcinoma: A Retrospective Single-Center Study.

Authors:  Kenichi Hirabayashi; Akiko Imoto; Misuzu Yamada; Atsuko Hadano; Nobuaki Kato; Youko Miyajima; Hitoshi Ito; Yoshiaki Kawaguchi; Toshio Nakagohri; Tetsuya Mine; Naoya Nakamura
Journal:  Front Oncol       Date:  2015-08-07       Impact factor: 6.244

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.